During the discussion, Hubbard and Theo explore how the compound is being studied for conditions such as opioid dependence and PTSD, share personal reflections on plant-based medicine, and talk about the policy and institutional barriers that can slow the adoption of new treatment approaches.
Videos
This Past Weekend w/ Theo Von - #596 W. Bryan Hubbard
November 1, 2025
W. Bryan Hubbard, CEO of Americans for Ibogaine and former chairman of the Kentucky Opioid Commission, joins Theo Von for a wide-ranging conversation about ibogaine and its potential role in treating addiction and trauma.